Henry Schein Inc (HSIC)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ
Market Cap: $9.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Henry Schein Inc (HSIC) Financials: Revenue, Profit and Cash Flow
Henry Schein reported revenue of $13.18B for the fiscal year ended Dec 31, 2025, up 4.0% from the year before. That year, net income was $419.00M with a net margin of 3.2%, operating cash flow was $712.00M and free cash flow was $573.00M. The quarter ended Sep 30, 2026 had revenue of $3.47B and net income of $126.00M.
Revenue and Margins
The operating margin was 5.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $11.57B, a compound annual rate of 1.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $13.18B | +4.0% | 31.1% | 5.0% | 3.2% |
| Dec 2024 | $12.67B | +2.7% | 31.7% | 4.9% | 3.1% |
| Dec 2023 | $12.34B | -2.4% | 31.3% | 5.0% | 3.5% |
| Dec 2022 | $12.65B | +2.0% | 30.3% | 5.9% | 4.5% |
| Dec 2021 | $12.40B | +22.6% | 29.6% | 6.9% | 5.3% |
| Dec 2020 | $10.12B | +1.3% | 27.8% | 5.3% | 4.2% |
| Dec 2019 | $9.99B | +6.0% | 31.0% | 7.2% | 7.2% |
| Dec 2018 | $9.42B | +6.0% | 30.9% | 6.4% | 6.0% |
| Dec 2017 | $8.88B | -23.2% | 30.9% | 7.5% | 5.2% |
| Dec 2016 | $11.57B | N/A | 27.9% | 6.7% | 4.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 5.3% from the year before. In the quarter ended Sep 2026, net income rose 15.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B |
| Cost of revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B |
| Gross profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B |
| Operating income | $653.00M | $621.00M | $615.00M | $747.00M | $852.00M | $535.00M | $718.26M | $600.62M | $669.76M | $771.57M |
| Net income | $419.00M | $398.00M | $436.00M | $566.00M | $660.00M | $420.00M | $719.14M | $562.13M | $459.29M | $556.39M |
| EBITDA | $961.00M | $917.00M | $860.00M | $960.00M | $1.06B | $717.00M | $900.28M | $740.99M | $802.28M | $944.23M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.47B | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B |
| Gross profit | $1.10B | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993.00M | $993.00M | $1.02B | $1.01B | $924.00M |
| Operating income | $193.00M | $171.00M | $182.00M | $163.00M | $164.00M | $151.00M | $175.00M | $155.00M | $157.00M | $159.00M | $150.00M | $39.00M |
| Net income | $126.00M | $102.00M | $112.00M | $103.00M | $109.00M | $94.00M | $113.00M | $96.00M | $99.00M | $105.00M | $98.00M | $17.00M |
Balance Sheet
As of Dec 2025, total debt of $3.11B exceeded cash and equivalents by $2.95B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Feb 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.81B | $7.86B |
| Current assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.03B | $4.09B |
| Cash and equivalents | $156.00M | $122.00M | $171.00M | $117.00M | $118.00M | $421.19M | $106.10M | $56.88M | $174.66M | $174.66M |
| Total liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.15B | $4.21B |
| Short-term debt | $797.00M | $706.00M | $414.00M | $109.00M | $62.00M | $183.20M | $133.82M | $959.74M | N/A | $758.31M |
| Long-term debt | $2.31B | $1.83B | $1.94B | $1.04B | $811.00M | $515.77M | $622.91M | $980.34M | $0 | $907.76M |
| Shareholder equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $3.66B | $2.81B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.51B | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | $10.57B |
| Total liabilities | $6.78B | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | $5.42B |
| Cash and equivalents | $184.00M | $157.00M | $138.00M | $156.00M | $136.00M | $145.00M | $127.00M | $122.00M | $126.00M | $138.00M | $159.00M | $171.00M |
| Shareholder equity | $3.16B | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | $3.65B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 80.5% of operating cash flow. Dividends and share repurchases together came to 167.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $712.00M | $848.00M | $500.00M | $602.00M | $710.00M | $599.00M | $654.09M | $684.71M | $545.51M | $642.58M |
| Capital expenditures | $139.00M | $148.00M | $147.00M | $96.00M | $79.00M | $49.00M | $76.22M | $71.28M | $62.40M | $70.18M |
| Free cash flow | $573.00M | $700.00M | $353.00M | $506.00M | $631.00M | $550.00M | $577.87M | $613.42M | $483.11M | $572.40M |
| Dividends paid | $30.00M | $54.00M | $47.00M | $21.00M | $26.00M | $8.00M | $51.50M | $7.35M | $15.05M | $105.08M |
| Share repurchases | $927.00M | $640.00M | $269.00M | $523.00M | $461.00M | $93.00M | $525.00M | $200.00M | $450.00M | $550.02M |
| Investing cash flow | -$400.00M | -$430.00M | -$1.14B | -$276.00M | -$677.00M | -$115.00M | -$424.37M | -$192.95M | -$342.28M | -$316.42M |
| Financing cash flow | -$188.00M | -$510.00M | $701.00M | -$315.00M | -$333.00M | -$187.00M | -$215.98M | -$603.78M | -$112.55M | -$327.34M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $161.00M | $242.00M | -$97.00M | $381.00M | $174.00M | $120.00M | $37.00M | $204.00M | $151.00M | $296.00M | $197.00M | -$32.00M |
| Capital expenditures | $30.00M | $30.00M | $25.00M | $43.00M | $33.00M | $32.00M | $31.00M | $36.00M | $34.00M | $37.00M | $41.00M | $39.00M |
| Free cash flow | $131.00M | $212.00M | -$122.00M | $338.00M | $141.00M | $88.00M | $6.00M | $168.00M | $117.00M | $259.00M | $156.00M | -$71.00M |
Frequently Asked Questions About HSIC
What is Henry Schein's annual revenue?
Henry Schein reported revenue of $13.18B for the fiscal year ended Dec 31, 2025.
How fast is Henry Schein's revenue growing?
Revenue was up 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.4%.
Is Henry Schein profitable?
Yes. Henry Schein reported net income of $419.00M for the fiscal year ended Dec 31, 2025, with a net margin of 3.2%.
How much free cash flow does HSIC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $712.00M minus capital expenditures of $139.00M produced free cash flow of $573.00M.
How much debt does Henry Schein have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.31B, short-term debt of $797.00M and cash and equivalents of $156.00M.
HSIC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts